bromocriptine has been researched along with Alzheimer Disease in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel-Daim, MM; Abdel-Fattah, AM; Algahtani, M; Alsaidalani, R; Buchade, RS; Chaudhari, SY; Debnath, S; Kesari, KK; Mheidat, M; Paul, T; Sayed, AA; Shaikh, AA; Sharma, D; Sharma, R | 1 |
| Amino, Y; Banno, H; Endo, K; Fujita, K; Ikeda, M; Inoue, H; Ishii, K; Ishikawa, H; Izumi, Y; Kanemaru, K; Kawakatsu, S; Kinoshita, A; Kondo, T; Kutoku, Y; Maki, T; Mori, K; Morita, S; Nakakura, A; Okunomiya, T; Shigenobu, K; Shindo, A; Shiota, S; Suehiro, T; Sunada, Y; Tada, H; Takahashi, R; Taruno, Y; Tomimoto, H; Uchikawa, O; Uozumi, R; Watanabe, T; Yasuda, K | 1 |
| Akaike, A; Honda, K; Kanki, R; Kihara, T; Nakamizo, T; Sawada, H; Shimohama, S; Yamashita, H | 1 |
| Asaba, H; Fujita, M; Higashi, S; Kuroda, K; Nishimoto, Y; Sakai, T | 1 |
| Lees, AJ; Phillips, M; Phuapradit, P; Stern, GM | 1 |
| Fujita, M; Shimizu, T | 1 |
| Ciolino, C; Rosse, R | 1 |
1 trial(s) available for bromocriptine and Alzheimer Disease
| Article | Year |
|---|---|
Repurposing bromocriptine for Aβ metabolism in Alzheimer's disease (REBRAnD) study: randomised placebo-controlled double-blind comparative trial and open-label extension trial to investigate the safety and efficacy of bromocriptine in Alzheimer's disease
Topics: Alzheimer Disease; Bromocriptine; Double-Blind Method; Drug Repositioning; Humans; Mutation; Presenilin-1; Treatment Outcome | 2021 |
6 other study(ies) available for bromocriptine and Alzheimer Disease
| Article | Year |
|---|---|
Wheat ergot fungus-derived and modified drug for inhibition of intracranial aneurysm rupture due to dysfunction of TLR-4 receptor in Alzheimer's disease.
Topics: Alzheimer Disease; Bromocriptine; Claviceps; Humans; Intracranial Aneurysm; Molecular Docking Simulation; Toll-Like Receptor 4; Triticum | 2023 |
Protective effect of dopamine D2 agonists in cortical neurons via the phosphatidylinositol 3 kinase cascade.
Topics: Alzheimer Disease; Animals; Bromocriptine; Cell Survival; Cells, Cultured; Cerebral Cortex; Dopamine Agonists; Dopamine D2 Receptor Antagonists; Enzyme Inhibitors; Fetus; Glutamic Acid; Ionophores; Neurons; Neuroprotective Agents; Nitric Oxide Donors; Phosphatidylinositol 3-Kinases; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Quinpirole; Rats; Receptors, Dopamine D2; Up-Regulation | 2002 |
Neuroendocrine studies in dementia patients: responses of plasma GH and PRL following bromocriptine administration.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Bromocriptine; Dementia, Multi-Infarct; Female; Growth Hormone; Humans; Male; Neurosecretory Systems; Prolactin | 1994 |
Bromocriptine in presenile dementia.
Topics: Alzheimer Disease; Bromocriptine; Dementia; Humans; Middle Aged | 1978 |
A neuroendocrinological investigation of patients with senile demantia of Alzheimer type. Plasma prolactin and GH responses following TRH, sulpiride, L-dopa, and bromocriptine administration.
Topics: Aged; Alzheimer Disease; Bromocriptine; Dopamine; Female; Growth Hormone; Humans; Hypothalamus; Kinetics; Levodopa; Male; Middle Aged; Prolactin; Sulpiride; Thyrotropin-Releasing Hormone | 1986 |
Dopamine agonists and neuroleptic malignant syndrome.
Topics: Alzheimer Disease; Amantadine; Basal Ganglia Diseases; Bromocriptine; Dantrolene; Humans; Male; Middle Aged; Neuroleptic Malignant Syndrome; Substance Withdrawal Syndrome | 1985 |